Traders bought shares of UnitedHealth Group Incorporated (NYSE:UNH) on weakness during trading hours on Tuesday after an insider sold shares in the company. $234.82 million flowed into the stock on the tick-up and $141.69 million flowed out of the stock on the tick-down, for a money net flow of $93.13 million into the stock. Of all equities tracked, UnitedHealth Group had the 3rd highest net in-flow for the day. UnitedHealth Group traded down ($3.54) for the day and closed at $194.65Specifically, Director William C. Ballard, Jr. sold 5,000 shares of the stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total value of $969,900.00. Following the completion of the sale, the director now owns 76,058 shares in the company, valued at $14,753,730.84. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Richard T. Burke sold 15,000 shares of the firm’s stock in a transaction dated Monday, August 21st. The stock was sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the sale, the director now owns 1,818,898 shares of the company’s stock, valued at approximately $348,700,935.58. The disclosure for this sale can be found here. In the last quarter, insiders sold 76,174 shares of company stock valued at $14,981,909. 0.89% of the stock is currently owned by corporate insiders.

UNH has been the subject of a number of research analyst reports. UBS AG restated an “overweight” rating on shares of UnitedHealth Group in a report on Thursday, August 24th. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $199.00 price objective for the company in a report on Tuesday, May 30th. BidaskClub upgraded shares of UnitedHealth Group from a “buy” rating to a “strong-buy” rating in a report on Saturday, July 8th. Morgan Stanley raised their price objective on shares of UnitedHealth Group from $202.00 to $210.00 and gave the stock an “overweight” rating in a report on Wednesday, June 28th. Finally, Vetr upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $186.50 price objective for the company in a report on Tuesday, May 30th. One investment analyst has rated the stock with a hold rating and twenty-five have assigned a buy rating to the company’s stock. UnitedHealth Group has a consensus rating of “Buy” and an average price target of $203.41.

The company’s 50-day moving average price is $195.48 and its 200-day moving average price is $181.07. The stock has a market capitalization of $188.20 billion, a P/E ratio of 23.38 and a beta of 0.63.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The business had revenue of $50.05 billion during the quarter, compared to the consensus estimate of $49.97 billion. During the same period in the prior year, the company posted $1.96 EPS. The firm’s revenue for the quarter was up 7.7% compared to the same quarter last year. Equities research analysts predict that UnitedHealth Group Incorporated will post $9.87 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th will be paid a $0.75 dividend. The ex-dividend date is Thursday, September 7th. This represents a $3.00 annualized dividend and a yield of 1.54%. UnitedHealth Group’s payout ratio is 35.13%.

A number of hedge funds have recently bought and sold shares of UNH. Patriot Financial Group Insurance Agency LLC boosted its position in shares of UnitedHealth Group by 1,722.9% during the 1st quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock valued at $106,000 after acquiring an additional 603 shares during the last quarter. Blue Chip Partners Inc. bought a new position in shares of UnitedHealth Group during the 2nd quarter valued at approximately $110,000. Kings Point Capital Management boosted its position in shares of UnitedHealth Group by 27.9% during the 1st quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock valued at $113,000 after acquiring an additional 150 shares during the last quarter. Bruderman Asset Management LLC bought a new position in shares of UnitedHealth Group during the 2nd quarter valued at approximately $114,000. Finally, Mitsubishi UFJ Securities Holdings Co. Ltd. boosted its position in shares of UnitedHealth Group by 433.3% during the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after acquiring an additional 520 shares during the last quarter. Institutional investors and hedge funds own 86.19% of the company’s stock.

WARNING: “Investors Buy UnitedHealth Group Incorporated (UNH) on Weakness After Insider Selling” was originally posted by Watch List News and is the property of of Watch List News. If you are reading this piece of content on another website, it was illegally copied and republished in violation of United States and international trademark & copyright law. The original version of this piece of content can be read at https://www.watchlistnews.com/investors-buy-unitedhealth-group-incorporated-unh-on-weakness-after-insider-selling/1574053.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.